AzTrials
AzTrials

Cholecystitis; GallstoneNCT06045546

A (5-5-5-8) Technique for Laparoscopic Cholecystectomy

A study testing 5-5-5-8 technique and 10-10-5-5 technique in people with Cholecystitis; Gallstone and Cholecystolithiasis, run by ClinAmygate at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The aim of this current study is to investigate the effectiveness and safety of a novel technique which is the 5-5-5-8 where the camera port is 5 mm. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
5-5-5-8 technique and 10-10-5-5 technique
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
524 participants
Where
1 siteEgypt
Study dates
20 Sep 2023to 20 Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged > 18 years
  • Patients eligible for LC during the study period

Who cannot join

  • refused to participate

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Aswan University Hospital

    Aswān

Other trials in Egypt

About this study

The aim of this current study is to investigate the effectiveness and safety of a novel technique which is the 5-5-5-8 where the camera port is 5 mm.

Read the detailed description

More than 50 different LC procedures are described in the literature, mostly as a result of changes made by surgeons to enhance cosmetic and postoperative results. Some adjustments include port size and/or number reductions relative to conventional LC usage. Each of these methods has benefits and drawbacks, and each one is appropriate for usage in particular circumstances.

The aim of this current study is to investigate the effectiveness and safety of a novel technique which is the 5-5-5-8 where the camera port is 5 mm.

The study has two analyses:

  1. at 6 month follow up
  2. at 24 months follow up
Being tested
5-5-5-8 technique, 10-10-5-5 technique
Medical subject headings
Cholecystitis, Gallstones, Cholecystolithiasis, Bronchiolitis Obliterans Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 5-5-5-8 techniqueProcedure or surgery

    the new technique of 5-5-5-8 for laparoscopic cholecystectomy

  • 10-10-5-5 techniqueProcedure or surgery

    the standard technique of 10-10-5-5 for laparoscopic cholecystectomy

Study groups in NCT06045546
Study groupRoleWhat they receive
5-5-5-8 groupExperimentalIn this group, the new 5-5-5-8 technique of laparoscopic cholecystectomy will be done.
Receives: Procedure: 5-5-5-8 technique
ControlActive comparatorIn this group, the 10-10-5-5 technique of laparoscopic cholecystectomy will be done.
Receives: Procedure: 10-10-5-5 technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of the operation

    Duration of the operation in minutes

    Measured: 1 hour

  2. Number of participants with Conversion to open surgery

    Number of participants with Failure of the technique and conversion to open surgery

    Measured: 1 hour

  3. Incidence of intra operative visceral injury

    Incidence of intra operative visceral injury

    Measured: 2 hours

  4. intra operative amount of blood loss

    intra operative amount of blood loss in ml

    Measured: 2 hours

  5. incidence of intra operative complications

    incidence of intra operative complications

    Measured: 2 hours

Secondary outcomes (5)
  1. post operative stay

    post operative stay in days

    Measured: 1 week

  2. incidence of port site infection

    incidence of infection of the port site

    Measured: 1 month

  3. Incidence of port site hernia

    Incidence of hernia of the port site

    Measured: 6 months

  4. Incidence of port site hernia

    Incidence of hernia of the port site

    Measured: 12 months

  5. Incidence of port site hernia

    Incidence of hernia of the port site

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2023
  2. Study start20 Sep 2023
  3. Primary completion20 Sep 2024
  4. Study completion20 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
524 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06045546
Sponsor's protocol ID
PR00C1947
Status last verified
Apr 2025
First submitted
11 Sep 2023
Last updated
16 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will be shared after approval of the IRB

Questions about this trial

What is this clinical trial studying?

A study testing 5-5-5-8 technique and 10-10-5-5 technique in people with Cholecystitis; Gallstone and Cholecystolithiasis, run by ClinAmygate at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 16 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of the operation (time frame: 1 hour). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2025; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in